China Resources Pharmaceutical Group Ltd.
3320
Κατάταξη σε μετοχές
#4342
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Τιμή μετοχής
$0.57730615
Κεφαλαιοποίηση
$3.63B
Αλλαγή (1 ημέρα)
-3.05%
Αλλαγή (1 έτος)
-6.33%
Χώρα
HK
Εμπόριο China Resources Pharmaceutical Group Ltd. (3320)
Κατηγορία
Healthcare
Έσοδα για την China Resources Pharmaceutical Group Ltd. (3320)
Έσοδα τον Jun 2026 TTM: $39.21B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της China Resources Pharmaceutical Group Ltd., τα τρέχοντα έσοδα της εταιρείας (TTM) είναι $39.21B. Το 2023, η εταιρεία είχε έσοδα $34.63B αύξηση σε σχέση με τα έσοδα του έτους 2022, τα οποία ήταν $32.52B. Τα έσοδα είναι το συνολικό ποσό που παράγει μια εταιρεία από τις πωλήσεις προϊόντων ή υπηρεσιών. Σε αντίθεση με τα κέρδη, δεν αφαιρούνται έξοδα.
Ιστορικό εσόδων για την China Resources Pharmaceutical Group Ltd. από 2013 έως 2026
Έσοδα στο τέλος κάθε έτους
| Έτος | Έσοδα | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $39.21B | 11.04% |
| 2024 | $35.32B | 1.99% |
| 2023 | $34.63B | 6.47% |
| 2022 | $32.52B | 7.07% |
| 2021 | $30.37B | 17.51% |
| 2020 | $25.85B | -1.53% |
| 2019 | $26.25B | 8.39% |
| 2018 | $24.22B | 9.67% |
| 2017 | $22.08B | 9.26% |
| 2016 | $20.21B | 6.88% |
| 2015 | $18.91B | 8.04% |
| 2014 | $17.50B | 16.05% |
| 2013 | $15.08B | 0.00% |
Έσοδα για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Έσοδα | Διαφορά Εσόδων | Χώρα |
|---|---|---|---|
| $2.54B | -93.53% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $830.81M | -97.88% |
US
|
|
| - | - |
IT
|
